Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan L A Voskuil

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
F1000Research|March 31, 2017
The challenges with the validation of research antibodiesJan L A Voskuil
Nature Protocols|December 17, 2024
YCharOS protocol for antibody validationFátima L Monteiro, Jan L A Voskuil, Cecilia Williams
Biochemistry|September 10, 2003
The intact human acetylcholinesterase C-terminal oligomerization domain is alpha-helical in situ and in isolation, but a shorter fragment forms beta-sheet-rich amyloid fibrils and protofibrillar oligomersMatthew G Cottingham, Jan L A Voskuil, David J T Vaux
Clinical and Translational Medicine|April 8, 2016
Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancersBjörn L D M Brücher, Yan Li, Philipp Schnabel, et al.
Mabs|August 5, 2020
The Antibody Society's antibody validation webinar seriesJan L A Voskuil, Anita Bandrowski, C Glenn Begley, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
F1000Research|March 31, 2017
The challenges with the validation of research antibodiesJan L A Voskuil
Nature Protocols|December 17, 2024
YCharOS protocol for antibody validationFátima L Monteiro, Jan L A Voskuil, Cecilia Williams
Biochemistry|September 10, 2003
The intact human acetylcholinesterase C-terminal oligomerization domain is alpha-helical in situ and in isolation, but a shorter fragment forms beta-sheet-rich amyloid fibrils and protofibrillar oligomersMatthew G Cottingham, Jan L A Voskuil, David J T Vaux
Clinical and Translational Medicine|April 8, 2016
Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancersBjörn L D M Brücher, Yan Li, Philipp Schnabel, et al.
Mabs|August 5, 2020
The Antibody Society's antibody validation webinar seriesJan L A Voskuil, Anita Bandrowski, C Glenn Begley, et al.
Pageof 1